Claims
- 1. The compound 1,3-di-n-propyl-8-(5-norbornen-2-yl) xanthine.
- 2. A pharmaceutical composition comprising the compound according to claim 1 or a physiologically acceptable acid addition salt thereof and a conventional excipient or carrier.
- 3. A method for the systemic treatment of senile dementia, Alzheimer's disease, organic brain syndrome, or Parkinson's disease, comprising the step of administering to a host suffering from one of said conditions a therapeutically effective amount of the pharmaceutical composition according to claim 2.
Priority Claims (1)
Number |
Date |
Country |
Kind |
38 43 117.3 |
Dec 1988 |
DEX |
|
Parent Case Info
This is a division of application Ser. No. 08/097,478, filed Jul. 27, 1993, now U.S. Pat. No. 5,532,368 which is a division of application Ser. No. 07/942,871, filed Sep. 10, 1992, now abandoned which is a continuation of application Ser. No. 691,193, filed Apr. 25, 1991 , now U.S. Pat. No. 5,175,291 which is a continuation of application Ser. No. 452,643, now abandoned.
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
5175291 |
Kufner-Muhl |
Dec 1992 |
|
5447933 |
Suzuki et al. |
Sep 1995 |
|
5525607 |
Suzuki et al. |
Jun 1996 |
|
Divisions (2)
|
Number |
Date |
Country |
Parent |
097478 |
Jul 1993 |
|
Parent |
942871 |
Sep 1992 |
|
Continuations (2)
|
Number |
Date |
Country |
Parent |
691193 |
Apr 1991 |
|
Parent |
452643 |
Dec 1989 |
|